Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study

BACKGROUND: Numerous medications have been tested on patients with pervasive developmental disorder not otherwise specified (PDD-NOS) and Asperger’s disorder. Although many of these medications have been demonstrated to be useful, no clear primary treatment for PDD-NOS and Asperger’s disorder has em...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyaoka, Tsuyoshi, Wake, Rei, Furuya, Motohide, Liaury, Kristian, Ieda, Masa, Kawakami, Kazunori, Tsuchie, Keiko, Inagaki, Takuji, Horiguchi, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533891/
https://www.ncbi.nlm.nih.gov/pubmed/23194148
http://dx.doi.org/10.1186/1471-244X-12-215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533891/
https://www.ncbi.nlm.nih.gov/pubmed/23194148
http://dx.doi.org/10.1186/1471-244X-12-215

Ejemplares similares